Literature DB >> 7634415

The methylation status of the gene for O6-methylguanine-DNA methyltransferase in human Mer+ and Mer- cells.

F Skorpen1, H E Krokan.   

Abstract

O6-Methylguanine-DNA methyltransferase (MGMT) plays an important role in protecting cells from the mutagenic potency of alkylating agents. This study addresses the role of DNA methylation in the expression of the human MGMT gene. Southern blot analysis of DNA from human Mer+ (MGMT proficient) and Mer- (MGMT deficient) cell lines demonstrated that the methylation state of a unique SmaI site in the MGMT gene promoter, previously shown by others to be invariably unmethylated in Mer+ cells and methylated in Mer- cells, did not correlate with the Mer phenotype. Neither was there any significant difference in the density of CpG methylation in the MGMT gene 5'-flanking sequences between Mer+ and Mer- cells. On the other hand, the body of the MGMT gene was less methylated in most Mer- cells relative to Mer+ cells, and in three of six Mer- cell lines the gene was essentially methylation-free. Interestingly, the Mer- cells that were hypomethylated in the MGMT gene also tended to be less methylated at other loci. Widespread hypomethylation is a frequent trait in carcinogenesis, and may be involved in development of the frequently found Mer- phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7634415     DOI: 10.1093/carcin/16.8.1857

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary human brain tumors.

Authors:  J R Silber; A Blank; M S Bobola; B A Mueller; D D Kolstoe; G A Ojemann; M S Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

4.  O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.

Authors:  S Halford; A Rowan; E Sawyer; I Talbot; I Tomlinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

5.  Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.

Authors:  Zhengdong Zhang; Luo Wang; Sheng Wei; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2010-03-04

6.  Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.

Authors:  Jie Zhang; Jian-Hui Yang; Jia Quan; Xing Kang; Hui-Juan Wang; Peng-Gao Dai
Journal:  Tumour Biol       Date:  2016-07-28

7.  Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.

Authors:  Christoph Sippl; Steffi Urbschat; Yoo Jin Kim; Sebastian Senger; Joachim Oertel; Ralf Ketter
Journal:  Oncol Lett       Date:  2017-11-24       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.